ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

UDG Udg Healthcare Public Limited Company

1,079.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Udg Healthcare Public Limited Company LSE:UDG London Ordinary Share IE0033024807 ORD EUR0.05 (CDI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,079.00 1,078.00 1,079.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

UDG Healthcare Public Limited Co. Notice of Interim Results (9202D)

03/05/2017 7:01am

UK Regulatory


Udg Healthcare Public (LSE:UDG)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Udg Healthcare Public Charts.

TIDMUDG

RNS Number : 9202D

UDG Healthcare Public Limited Co.

03 May 2017

3 May 2017

UDG Healthcare plc

Notice of Interim Results

UDG Healthcare plc ("the Group"), a leading international healthcare services provider, will issue its interim results for the half year ended 31 March 2017 at 07:00am (BST) on Tuesday 23 May 2017.

Brendan McAtamney, CEO and Alan Ralph, CFO will be hosting a presentation for analysts and investors at the London Stock Exchange at 08:30am (BST) to discuss the company's half year results and provide an update on each of the Group's divisions.

Analysts and investors wishing to attend are asked to contact Powerscourt on the details below, as all attendees need to be pre-registered. The presentation will also be available via live audio webcast and conference call, the details of which are below.

Audio webcast:

http://edge.media-server.com/m/p/ee9kdegt

Conference call dial-in details:

 
 UK                          +44-(0)203-427-1903 
--------------------------  -------------------- 
 Ireland                     +353-1-246-5603 
--------------------------  -------------------- 
 United States of America    +1-646-254-3388 
--------------------------  -------------------- 
 Participant Code            1935522 
--------------------------  -------------------- 
 

For further information, please contact:

 
 UDG Healthcare plc 
  Keith Byrne 
 Head of Investor Relations, Strategy 
  & Corporate Communications 
 Tel: +353-1-468-9000 
 
 Powerscourt 
 Lisa Kavanagh / Nick Brown 
 Tel: +44-207-250-1446 
  udghealthcare@powerscourt-group.com 
 

About UDG Healthcare plc:

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering commercial, clinical, communications and packaging services to the healthcare industry, employing over 8,000 people with operations in 23 countries and delivering services in over 50 countries.

UDG Healthcare plc operates across three divisions: Ashfield, Sharp and Aquilant.

Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across two broad areas of activity: commercial & clinical services, and communications services. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.

Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, operating from state of the art facilities across the US and Europe. Sharp is also a world leader in 'Track and Trace' serialisation services, which will require all prescription drugs to have a unique serial code for authentication and traceability.

Aquilant is a leading provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.

For more information, please go to: www.udghealthcare.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORSSIFEEFWSEEI

(END) Dow Jones Newswires

May 03, 2017 02:01 ET (06:01 GMT)

1 Year Udg Healthcare Public Chart

1 Year Udg Healthcare Public Chart

1 Month Udg Healthcare Public Chart

1 Month Udg Healthcare Public Chart

Your Recent History

Delayed Upgrade Clock